drugset / Trial / NCT00689793

Clinical Evaluation of Iron Treatment Efficiency Among Non-anemic But Iron-deficient Female Blood Donors

NCT00689793

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the subjective response of iron substitution (Tardyferon®) on fatigue in women blood donors with a mean serum ferritin \< 30ng/ml and to assess variation of ferritin and hemoglobin after a blood donation.

Timeline

Start
2008-11
Primary completion
2010-10
Completion
2011-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ferrous Sulfate Diagnostic / imaging agent 80 mg Oral